{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T06:37:48Z","timestamp":1774852668584,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbrc.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T19:42:40Z","timestamp":1646682160000},"page":"138-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Schixator, a new FXa inhibitor from Schistosoma japonicum with antithrombotic effect and low bleeding risk"],"prefix":"10.1016","volume":"603","author":[{"given":"Li","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangmei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.03.005_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/14728222.2011.553608","article-title":"Blood coagulation factor Xa as an emerging drug target","volume":"15","author":"Borensztajn","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2022.03.005_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1538-7836.2007.02552.x","article-title":"Factor Xa or thrombin: is thrombin a better target?","volume":"5","author":"Weitz","year":"2007","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.bbrc.2022.03.005_bib3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1074\/jbc.M807340200","article-title":"Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa","volume":"284","author":"Izaguirre","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.03.005_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162997","article-title":"Bee venom: overview of main compounds and bioactivities for therapeutic interests","volume":"24","author":"Wehbe","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2022.03.005_bib5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/14712598.2017.1346606","article-title":"Treating autoimmune disorders with venom-derived peptides","volume":"17","author":"Shen","year":"2017","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1096\/fj.15-274787","article-title":"Human alpha-defensins are immune-related Kv1.3 channel inhibitors: new support for their roles in adaptive immunity","volume":"29","author":"Xie","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2022.03.005_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10030126","article-title":"Toxins in drug discovery and pharmacology","volume":"10","author":"Peigneur","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.bbrc.2022.03.005_bib8","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3390\/md12052970","article-title":"Conotoxins targeting nicotinic acetylcholine receptors: an overview","volume":"12","author":"Lebbe","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bbrc.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1096\/fj.14-251967","article-title":"Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases","volume":"28","author":"Chhabra","year":"2014","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1160\/TH04-01-0047","article-title":"Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide","volume":"92","author":"Hagemeyer","year":"2004","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.bbrc.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.2333510","article-title":"Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa","volume":"248","author":"Waxman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.03.005_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.2018889493","article-title":"NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition","volume":"134","author":"De Paula","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.03.005_bib13","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1182\/blood-2001-12-0237","article-title":"Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa\/tissue factor complex","volume":"99","author":"Francischetti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biochi.2014.07.006","article-title":"A\u00a0new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa","volume":"105","author":"Thakur","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbrc.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"D728","DOI":"10.1093\/nar\/gks1087","article-title":"SchistoDB: an updated genome resource for the three key schistosomes of humans","volume":"41","author":"Zerlotini","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2022.03.005_bib16","first-page":"132","article-title":"Schistosomiasis: clinical features and relevance to hematology","volume":"19","author":"Mahmoud","year":"1982","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-030-18616-6_3","article-title":"Schistosomiasis","volume":"1154","author":"LoVerde","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molbiopara.2016.07.009","article-title":"Schistosoma bovis-host interplay: proteomics for knowing and acting","volume":"215","author":"de la Torre-Escudero","year":"2017","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003781","article-title":"Interference with the host haemostatic system by schistosomes","volume":"9","author":"Mebius","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2022.03.005_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006870","article-title":"Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation","volume":"14","author":"Morais","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2022.03.005_bib21","article-title":"Genomic and structural characterization of Kunitz-type peptide LmKTT-1a highlights diversity and evolution of scorpion potassium channel toxins","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.03.005_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027548","article-title":"SdPI, the first functionally characterized Kunitz-type trypsin inhibitor from scorpion venom","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.03.005_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2014.03.101","article-title":"Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues","volume":"447","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.03.005_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jbt.21538","article-title":"BF9, the first functionally characterized snake toxin peptide with Kunitz-type protease and potassium channel inhibiting properties","volume":"28","author":"Yang","year":"2014","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijbiomac.2015.05.027","article-title":"SjAPI-2 is the first member of a new neurotoxin family with Ascaris-type fold and KCNQ1 inhibitory activity","volume":"79","author":"Chen","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.peptides.2015.07.002","article-title":"Engineering a peptide inhibitor towards the KCNQ1\/KCNE1 potassium channel (IKs)","volume":"71","author":"Hu","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.bbrc.2022.03.005_bib27","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1074\/jbc.M112.343996","article-title":"Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family","volume":"287","author":"Chen","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.03.005_bib28","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1074\/jbc.M110.191163","article-title":"Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant","volume":"286","author":"Bajaj","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.03.005_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jth.12797","article-title":"Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity","volume":"13","author":"Chen","year":"2015","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.bbrc.2022.03.005_bib30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ijbiomac.2018.08.178","article-title":"Engineering varied serine protease inhibitors by converting P1 site of BF9, a weakly active Kunitz-type animal toxin","volume":"120","author":"Ding","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.thromres.2013.03.016","article-title":"Darexaban: anticoagulant effects in mice and human plasma in\u00a0vitro, antithrombotic effects in thrombosis and bleeding models in mice and effects of anti-inhibitor coagulant complex and recombinant factor VIIa","volume":"131","author":"Kaku","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbrc.2022.03.005_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijid.2017.10.024","article-title":"Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni","volume":"66","author":"Ranasinghe","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2022.03.005_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007612","article-title":"An improved genome assembly of the fluke Schistosoma japonicum","volume":"13","author":"Luo","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.bbrc.2022.03.005_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature08140","article-title":"The Schistosoma japonicum genome reveals features of host-parasite interplay","volume":"460","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2022.03.005_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pt.2004.04.012","article-title":"Schistosome transcriptome: insights and perspectives for functional genomics","volume":"20","author":"Verjovski-Almeida","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.2019000919","article-title":"Novel antithrombotic strategies for treatment of venous thromboembolism","volume":"135","author":"Weitz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.03.005_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/ATVBAHA.119.313503","article-title":"Plasma kallikrein contributes to coagulation in the absence of factor XI by activating factor IX","volume":"40","author":"Visser","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib38","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/jth.13760","article-title":"A\u00a0kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release","volume":"15","author":"Steen Burrell","year":"2017","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.bbrc.2022.03.005_bib39","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.12302","article-title":"Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer","volume":"11","author":"Woodruff","year":"2013","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.bbrc.2022.03.005_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.hoc.2016.05.007","article-title":"The intrinsic pathway of coagulation as a target for antithrombotic therapy","volume":"30","author":"Wheeler","year":"2016","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.bbrc.2022.03.005_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/187152810791292890","article-title":"Blood coagulation as an intrinsic pathway for proinflammation: a mini review","volume":"9","author":"Chu","year":"2010","journal-title":"Inflamm. Allergy - Drug Targets"},{"key":"10.1016\/j.bbrc.2022.03.005_bib42","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1182\/blood-2010-04-277798","article-title":"Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.03.005_bib43","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/med.21489","article-title":"Heparin mimetics with anticoagulant activity","volume":"38","author":"Nahain","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2022.03.005_bib44","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.03.005_bib45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2022.03.005_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrcardio.2017.223","article-title":"Reversal agents for non-vitamin K antagonist oral anticoagulants","volume":"15","author":"Levy","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2022.03.005_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2022.03.005_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nrcardio.2014.204","article-title":"Balancing ischaemia and bleeding risks with novel oral anticoagulants","volume":"12","author":"Baber","year":"2014","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22003242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22003242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:16:42Z","timestamp":1757765802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22003242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":48,"alternative-id":["S0006291X22003242"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.005","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schixator, a new FXa inhibitor from Schistosoma japonicum with antithrombotic effect and low bleeding risk","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}